Business Context and Reporting Period
This Form 6-K filing by Alpha Tau Medical Ltd. covers the month of June 2026. The report details the outcomes of the Company's Annual General Meeting of Shareholders held on June 23, 2026, at its headquarters in Jerusalem, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance report and does not contain financial performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document focuses exclusively on shareholder approvals regarding corporate governance and personnel.
Guidance, Outlook, and Management Commentary
The filing outlines six key proposals approved by shareholders at the Annual General Meeting:
- Re-election of David Milch and Ruth Alon as Class II directors until 2029.
- Re-approval of the Compensation Policy for Executive Officers and Directors.
- Approval of Uzi Sofer's re-appointment as Chairman of the Board while serving as CEO.
- Approval of a specific compensation package for CEO and Chairman Uzi Sofer.
- Approval of the extension of terms for certain stock options held by directors and officers.
- Re-appointment of Kost Forer Gabbay & Kasierer (Ernst & Young Global) as the independent registered public accounting firm for the year ending December 31, 2026.
All proposals were approved by the requisite majorities in accordance with the Companies Law and the Company's Articles of Association.
Key Facts for Investor Verification
- Verify the specific terms of the compensation package approved for CEO Uzi Sofer in the attached Proxy Statement (Exhibit 99.1).
- Confirm the details regarding the extension of option terms for directors and officers.
- Note that the independent auditor for the 2026 fiscal year remains Kost Forer Gabbay & Kasierer.
- Recognize that this filing contains no financial results; investors should refer to Form 20-F or other financial reports for performance metrics.